GHD Reversal Trial Advertising V1.0, [11 August 2023]
All Serious Adverse Events reported for the GHD Reversal Trial require clinical coding using the Common Terminology Criteria for Adverse Events (CTCAE) system. Please see below for CTCAE v5.0 for reference.
CTCAE v5.0
A Frequently Asked Questions document can be found below, documenting answers to questions that parents/carers/ patients may have. This will be updated as and when additional questions arise.
Frequently Asked Questions